Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168367723> ?p ?o ?g. }
- W2168367723 abstract "15520 Background: The optimum radiosensitizing dose and schedule of gemcitabine for squamous cell carcinoma of head and neck are not known. The objectives of this study were to evaluate the efficacy and toxicity of weekly gemcitabine as a radiosensitizer concurrent with radical radiotherapy in locally advanced head and neck cancer. Method: Thirty-nine patients with stage III or IV B inoperable carcinoma of head and neck were enrolled. Eligible patients had histopathologically confirmed squamous cell carcinoma with age between 18–70 years. Patients had a KPS >70 with an adequate marrow, hepatic and renal function. No prior chemotherapy or radiotherapy was allowed. Patients with nasopharyngeal, glottic or sub-glottic cancer were excluded. Gemcitabine 150 mg/m 2 or a total dose not exceeding 200 mg was given on day 1,8,15,22,29, and 36 during radiation treatment. Gemcitabine was infused in 200 ml of normal saline in 2 hours and radiation was delivered two hours after the completion of gemcitabine infusion. Conventional fractionation was used to deliver a total dose of 66 Gy. CTC version 2.0 of NCI and RTOG/EORTC Late Radiation Morbidity Scoring Scheme were used for evaluation of toxicity and RECIST was used for response evaluation. Results: Only 35 patients were considered evaluable for response. Complete response was seen in 8 (22.9%) (95% CI; 10.4–40.1%), partial response in 25 (71.4%), with an overall response rate of 94.3% (95% CI; 80.8–99.3%). All the thirty-nine patients were evaluable for toxicity. Grade 3 and 4 mucositis was seen in 28 (71.8%) and 2 (5.1%) patients respectively. Grade 3 pharyngeal toxicity was seen in 6 (15.4%). One patient developed pharyngo-cutaneous fistula. Despite vigorous symptomatic and supportive care acute toxicities led to treatment interruption in 16 (41%) of patients. Conclusion: Weekly gemcitabine at a dose of 150mg/m 2 concurrent with radiation therapy gives a high overall response rate and a high rate of acute toxicity. No significant financial relationships to disclose." @default.
- W2168367723 created "2016-06-24" @default.
- W2168367723 creator A5001630827 @default.
- W2168367723 creator A5016992698 @default.
- W2168367723 creator A5017604958 @default.
- W2168367723 creator A5018324103 @default.
- W2168367723 creator A5032811079 @default.
- W2168367723 creator A5036597343 @default.
- W2168367723 creator A5048077818 @default.
- W2168367723 creator A5057492619 @default.
- W2168367723 creator A5067453949 @default.
- W2168367723 creator A5088068368 @default.
- W2168367723 date "2006-06-20" @default.
- W2168367723 modified "2023-09-26" @default.
- W2168367723 title "Phase II study of gemcitabine concurrent with radiation in locally advanced squamous cell carcinoma of head and neck: Trial of the Cancer Research Group Pakistan" @default.
- W2168367723 cites W1536690700 @default.
- W2168367723 cites W1799770165 @default.
- W2168367723 cites W1862136029 @default.
- W2168367723 cites W1945923877 @default.
- W2168367723 cites W1977306578 @default.
- W2168367723 cites W2000588279 @default.
- W2168367723 cites W2008318438 @default.
- W2168367723 cites W2022101062 @default.
- W2168367723 cites W2029923264 @default.
- W2168367723 cites W2043615844 @default.
- W2168367723 cites W2043945205 @default.
- W2168367723 cites W2083513265 @default.
- W2168367723 cites W2087884039 @default.
- W2168367723 cites W2104854477 @default.
- W2168367723 cites W2125919881 @default.
- W2168367723 cites W2138070201 @default.
- W2168367723 cites W2144599319 @default.
- W2168367723 cites W2145703501 @default.
- W2168367723 cites W2146148650 @default.
- W2168367723 cites W2151701047 @default.
- W2168367723 cites W2152609192 @default.
- W2168367723 cites W2157885764 @default.
- W2168367723 cites W2160580799 @default.
- W2168367723 cites W2167805334 @default.
- W2168367723 cites W2278556698 @default.
- W2168367723 cites W2331395194 @default.
- W2168367723 cites W2401189462 @default.
- W2168367723 cites W2409482254 @default.
- W2168367723 cites W2409528220 @default.
- W2168367723 cites W2417739967 @default.
- W2168367723 cites W2419767826 @default.
- W2168367723 cites W2468257596 @default.
- W2168367723 doi "https://doi.org/10.1200/jco.2006.24.18_suppl.15520" @default.
- W2168367723 hasPublicationYear "2006" @default.
- W2168367723 type Work @default.
- W2168367723 sameAs 2168367723 @default.
- W2168367723 citedByCount "1" @default.
- W2168367723 crossrefType "journal-article" @default.
- W2168367723 hasAuthorship W2168367723A5001630827 @default.
- W2168367723 hasAuthorship W2168367723A5016992698 @default.
- W2168367723 hasAuthorship W2168367723A5017604958 @default.
- W2168367723 hasAuthorship W2168367723A5018324103 @default.
- W2168367723 hasAuthorship W2168367723A5032811079 @default.
- W2168367723 hasAuthorship W2168367723A5036597343 @default.
- W2168367723 hasAuthorship W2168367723A5048077818 @default.
- W2168367723 hasAuthorship W2168367723A5057492619 @default.
- W2168367723 hasAuthorship W2168367723A5067453949 @default.
- W2168367723 hasAuthorship W2168367723A5088068368 @default.
- W2168367723 hasConcept C116263406 @default.
- W2168367723 hasConcept C121608353 @default.
- W2168367723 hasConcept C126322002 @default.
- W2168367723 hasConcept C141071460 @default.
- W2168367723 hasConcept C143998085 @default.
- W2168367723 hasConcept C2776530083 @default.
- W2168367723 hasConcept C2776694085 @default.
- W2168367723 hasConcept C2778496288 @default.
- W2168367723 hasConcept C2780258809 @default.
- W2168367723 hasConcept C29730261 @default.
- W2168367723 hasConcept C509974204 @default.
- W2168367723 hasConcept C71924100 @default.
- W2168367723 hasConceptScore W2168367723C116263406 @default.
- W2168367723 hasConceptScore W2168367723C121608353 @default.
- W2168367723 hasConceptScore W2168367723C126322002 @default.
- W2168367723 hasConceptScore W2168367723C141071460 @default.
- W2168367723 hasConceptScore W2168367723C143998085 @default.
- W2168367723 hasConceptScore W2168367723C2776530083 @default.
- W2168367723 hasConceptScore W2168367723C2776694085 @default.
- W2168367723 hasConceptScore W2168367723C2778496288 @default.
- W2168367723 hasConceptScore W2168367723C2780258809 @default.
- W2168367723 hasConceptScore W2168367723C29730261 @default.
- W2168367723 hasConceptScore W2168367723C509974204 @default.
- W2168367723 hasConceptScore W2168367723C71924100 @default.
- W2168367723 hasLocation W21683677231 @default.
- W2168367723 hasOpenAccess W2168367723 @default.
- W2168367723 hasPrimaryLocation W21683677231 @default.
- W2168367723 hasRelatedWork W1883000310 @default.
- W2168367723 hasRelatedWork W1987418475 @default.
- W2168367723 hasRelatedWork W2020319882 @default.
- W2168367723 hasRelatedWork W2043943046 @default.
- W2168367723 hasRelatedWork W2141904859 @default.
- W2168367723 hasRelatedWork W2161675417 @default.
- W2168367723 hasRelatedWork W2354390866 @default.
- W2168367723 hasRelatedWork W2406870619 @default.
- W2168367723 hasRelatedWork W2412023832 @default.
- W2168367723 hasRelatedWork W2418089200 @default.